Arthur David J.'s Form 4 filing
Decoy Therapeutics Inc. (DCOY) · filed Aug 17, 2021
- Accession no.
- 0001615219-21-000087
- Filed
- Aug 17, 2021
- Trade date
- Aug 17, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $3.58K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arthur David J.CIK 0001769331 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Common Stock | PPurchaseAcquired | +2,000 | $0.90 | +$1,800 | 100,247 | Indirect | |
| Aug 17, 2021 | Common Stock | PPurchaseAcquired | +2,000 | $0.89 | +$1,780 | 102,247 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.